STKL...SunOpta says considers an equity financing for its bioProcess group (STKL) 9.50 : Co announces that it has engaged two investment banks as agents with an intention of raising up to $30 mln U.S. in equity capital in a private placement for a minority position within the SunOpta BioProcess Group.